Search Results 1-10 of 10601 for cyclosporine

1. Cyclosporine (oral route) - Mayo Clinic

   Cyclosporine works by suppressing the immune system to prevent the white blood cells from trying to get rid of the transplanted organ. Cyclosporine is also used ...

2. Cyclosporine (intravenous route) - Side effects & uses - Mayo Clinic

   Cyclosporine works by suppressing the immune system to prevent the white blood cells from trying to get rid of the transplanted organ. This medicine is to be ...

3. Cyclosporine (ophthalmic route) - Mayo Clinic

   Description. Cyclosporine eye drops are used to increase tear production in patients who have a certain eye condition (eg, keratoconjunctivitis sicca).

5. Medicine use in transplant recipients - Mayo Clinic

   Cyclosporine works by stopping the production of certain cells. This helps prevent rejection. Cyclosporine is typically used in people who receive kidney, liver ...

6. Cyclobenzaprine (oral route) - Mayo Clinic

   It helps relieve pain, stiffness, and discomfort caused by strains, sprains, or injuries to your muscles. However, this medicine does not take the place of rest ...

7. Sirolimus (oral route) - Side effects & dosage - Mayo Clinic

   ... cyclosporine. Sirolimus should be taken 4 hours after cyclosporine modified oral solution or cyclosporine modified capsules (Neoral®). If you have any ...

8. Two kidney disease therapies square off in MENTOR trial - Mayo Clinic News Network

   Cyclosporine works by inhibiting the action of immune cells, keeping the body from attacking itself. The issue with this treatment, says Dr. Fervenza, is that ...

9. Isosulfan blue (subcutaneous route) - Side effects & uses - Mayo Clinic

   This creates a contrast between the lymph nodes and vessels and helps your doctor check for serious medical problems such as lymphedema, chyluria (lymph in the ...

10. A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial To Demonstrate The Efficacy And Safety Of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered Via The PARI Investigational EFlow® Device Plus Standard Of Care Versus Standard Of Care Alone In The Treatment Of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome In Patients Post Double Lung Transplantation (BOSTON-2) - Mayo Clinic

    A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial To Demonstrate The Efficacy And Safety Of Liposomal Cyclosporine A (L-CsA) ...